Back to ACRS

CITADEL ADVISORS LLC → ACRS

CITADEL ADVISORS LLC ACRS Position History

Aclaris Therapeutics, Inc. • Healthcare

Quarters held
12
Latest value
$550K
Q2 2026
Peak value
$8.3M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$1.6M
Q1 2026$1.7M
Q1 2026$6.8M
Q1 2026$384K
Q2 2026$997K
Q2 2026$2.8M
Q2 2026$8.3M
Q2 2026$550K
Q2 2026$997K
Q2 2026$2.8M
Q2 2026$8.3M
Q2 2026$550K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$550K104.0K——
Q2 2026$8.3M1.57M——
Q2 2026$2.8M521.0K——
Q2 2026$997K188.5K——
Q2 2026$550K104.0K——
Q2 2026$8.3M1.57M——
Q2 2026$2.8M521.0K——
Q2 2026$997K188.5K——
Q1 2026$384K102.3K——
Q1 2026$6.8M1.82M——
Q1 2026$1.7M466.4K——
Q1 2026$1.6M425.1K——

Other funds holding ACRS

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
SPY

SPDR S&P 500 ETF TR

$3B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
NVDA

NVIDIA CORPORATION

$2.1B
SPY

SPDR S&P 500 ETF TR

$2.1B
NVDA

NVIDIA CORPORATION

$2.1B